UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Recognition and management of allergic disease during pregnancy

Author
Michael Schatz, MD, MS
Section Editors
Bruce S Bochner, MD
Charles J Lockwood, MD, MHCM
Deputy Editor
Anna M Feldweg, MD

INTRODUCTION

Pregnancy may be complicated by new-onset or pre-existing allergic disease, including rhinitis, urticaria, angioedema, or atopic dermatitis (AD). In contrast to asthma in pregnancy, relatively few studies have examined the management of other allergic disorders in pregnant women.

This topic reviews the recognition and management of rhinitis, urticaria, angioedema, and AD in pregnancy, as well as general principles of medication use during pregnancy. The diagnosis and management of asthma in pregnancy, anaphylaxis in pregnancy, the various dermatoses of pregnancy, and the management of allergic rhinitis in nonpregnant patients are discussed separately. (See "Physiology and clinical course of asthma in pregnancy" and "Management of asthma during pregnancy" and "Anaphylaxis in pregnant and breastfeeding women" and "Dermatoses of pregnancy" and "Pharmacotherapy of allergic rhinitis".)

General approach to treating allergy in pregnancy — In any form of allergic disease, a primary element of management is avoidance of the culprit allergen, when possible. Allergen avoidance is particularly important during pregnancy because the use of systemic medications should be minimized, if possible.

Women with significant allergic disease should ideally be evaluated before they become pregnant, so that any skin testing, challenge procedures, or other exposures that might be necessary for definitive diagnosis can be safely performed. This is especially important for women with the following:

Allergies to medications that may be needed during pregnancy, such as local anesthetics or drugs used in general anesthesia. (See "Perioperative anaphylaxis: Evaluation and prevention of recurrent reactions".)

                                         

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Oct 20 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Scialli A, Lone A. Pregnancy effects of specific medications used to treat asthma and immunological diseases. In: Asthma and immunological diseases in pregnancy and early infancy, Schatz M, Zeiger RS, Claman HN (Eds), Marcel Dekker, New York 1998.
  2. Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol 1978; 61:268.
  3. FDA Announcement: https://www.federalregister.gov/articles/2014/12/04/2014-28241/content-and-format-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for?source=govdelivery&utm_medium=email&utm_source=govdelivery (Accessed on January 23, 2015).
  4. Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc 1988; 9:545.
  5. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000; 110:1189.
  6. Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Physician 2009; 80:1117.
  7. Garavello W, Somigliana E, Acaia B, et al. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol 2010; 151:137.
  8. Eccles R. Nasal airflow in health and disease. Acta Otolaryngol 2000; 120:580.
  9. Schatz M, Zeiger RS, Falkoff R, et al. Asthma and allergic diseases during pregnancy. In: Middleton's allergy: Principles and practice, 7th ed, Adkinson NF, Bochner BS, Burks AW, et al (Eds), Mosby, St. Louis 2014. p.951.
  10. Turnbull GL, Rundell OH, Rayburn WF, et al. Managing pregnancy-related nocturnal nasal congestion. The external nasal dilator. J Reprod Med 1996; 41:897.
  11. Stroud RH, Wright ST, Calhoun KH. Nocturnal nasal congestion and nasal resistance. Laryngoscope 1999; 109:1450.
  12. Gani F, Braida A, Lombardi C, et al. Rhinitis in pregnancy. Eur Ann Allergy Clin Immunol 2003; 35:306.
  13. Ellegård EK. The etiology and management of pregnancy rhinitis. Am J Respir Med 2003; 2:469.
  14. Ellegård E, Hellgren M, Torén K, Karlsson G. The incidence of pregnancy rhinitis. Gynecol Obstet Invest 2000; 49:98.
  15. Ellegård EK. Pregnancy rhinitis. Immunol Allergy Clin North Am 2006; 26:119.
  16. Ellegård EK. Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol 2004; 26:149.
  17. Ellegård EK, Karlsson NG, Ellegård LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol 2007; 19:305.
  18. Ellegård E, Karlsson G. IgE-mediated reactions and hyperreactivity in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg 1999; 125:1121.
  19. Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci 2001; 26:394.
  20. Kircher S, Schatz M, Long L. Variables affecting asthma course during pregnancy. Ann Allergy Asthma Immunol 2002; 89:463.
  21. Somoskövi A, Bártfai Z, Tamási L, et al. Population-based case-control study of allergic rhinitis during pregnancy for birth outcomes. Eur J Obstet Gynecol Reprod Biol 2007; 131:21.
  22. Franklin KA, Holmgren PA, Jönsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117:137.
  23. Ayrım A, Keskin EA, Ozol D, et al. Influence of self-reported snoring and witnessed sleep apnea on gestational hypertension and fetal outcome in pregnancy. Arch Gynecol Obstet 2011; 283:195.
  24. O'Brien LM, Bullough AS, Owusu JT, et al. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol 2012; 207:487.e1.
  25. National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on February 23, 2010).
  26. Wilson J. Use of sodium cromoglycate during pregnancy. J Pharm Med 1982; 8:45.
  27. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 2005; 115:34.
  28. Bérard A, Sheehy O, Kurzinger ML, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol 2016; 138:97.
  29. Namazy JA, Schatz M. The safety of intranasal steroids during pregnancy: A good start. J Allergy Clin Immunol 2016; 138:105.
  30. Shaikh WA. A retrospective study on the safety of immunotherapy in pregnancy. Clin Exp Allergy 1993; 23:857.
  31. Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997; 78:157.
  32. Diav-Citrin O, Shechtman S, Aharonovich A, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol 2003; 111:1239.
  33. Moretti ME, Caprara D, Coutinho CJ, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin Immunol 2003; 111:479.
  34. Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 2005; 28:707.
  35. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002; 11:146.
  36. Yau WP, Mitchell AA, Lin KJ, et al. Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol 2013; 178:198.
  37. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy, PSG Publishing, Littleton, MA 1977.
  38. Rayburn WF, Anderson JC, Smith CV, et al. Uterine and fetal Doppler flow changes from a single dose of a long-acting intranasal decongestant. Obstet Gynecol 1990; 76:180.
  39. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45:361.
  40. Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996; 54:84.
  41. Källén BA, Olausson PO. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol 2006; 194:480.
  42. Smith CV, Rayburn WF, Anderson JC, et al. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow. Obstet Gynecol 1990; 76:803.
  43. Hatton RC, Winterstein AG, McKelvey RP, et al. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother 2007; 41:381.
  44. Horak F, Zieglmayer P, Zieglmayer R, et al. A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol 2009; 102:116.
  45. Meltzer EO, Ratner PH, McGraw T. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study. J Allergy Clin Immunol Pract 2015; 3:702.
  46. Smith NT, Corbascio AN. The use and misuse of pressor agents. Anesthesiology 1970; 33:58.
  47. Cottle MK, Van Petten GR, van Muyden P. Effects of phenylephrine and sodium salicylate on maternal and fetal cardiovascular indices and blood oxygenation in sheep. Am J Obstet Gynecol 1982; 143:170.
  48. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 1979; 109:433.
  49. Dombrowski MP, Schatz M, ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol 2008; 111:457.
  50. Sorri M, Hartikainen-Sorri AL, Kärjä J. Rhinitis during pregnancy. Rhinology 1980; 18:83.
  51. Namazy JA, Schatz M, Yang SJ, Chen W. Antibiotics for respiratory infections during pregnancy: prevalence and risk factors. J Allergy Clin Immunol Pract 2016; 4:1256.
  52. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969; 81:588.
  53. Palmer GW, Claman HN. Pregnancy and immunology: selected aspects. Ann Allergy Asthma Immunol 2002; 89:350.
  54. Bierman SM. Autoimmune progesterone dermatitis of pregnancy. Arch Dermatol 1973; 107:896.
  55. Farah FS, Shbaklu Z. Autoimmune progesterone urticaria. J Allergy Clin Immunol 1971; 48:257.
  56. Boiko S, Zeiger R. Diagnosis and treatment of atopic dermatitis, urticaria, and angioedema during pregnancy. Immunol Allergy Clin North Am 2000; 20:839.
  57. Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol 2003; 90:469.
  58. Oskay T, Kutluay L, Kaptanoğlu A, Karabacak O. Autoimmune progesterone dermatitis. Eur J Dermatol 2002; 12:589.
  59. Cocuroccia B, Gisondi P, Gubinelli E, Girolomoni G. Autoimmune progesterone dermatitis. Gynecol Endocrinol 2006; 22:54.
  60. Walling HW, Scupham RK. Autoimmune progesterone dermatitis. Case report with histologic overlap of erythema multiforme and urticaria. Int J Dermatol 2008; 47:380.
  61. Prieto-Garcia A, Sloane DE, Gargiulo AR, et al. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril 2011; 95:1121.e9.
  62. Meggs WJ, Pescovitz OH, Metcalfe D, et al. Progesterone sensitivity as a cause of recurrent anaphylaxis. N Engl J Med 1984; 311:1236.
  63. Bhatia PL, Singh MS, Jha BK. Laryngopathia gravidarum. Ear Nose Throat J 1981; 60:408.
  64. ROTH HL, KIERLAND RR. THE NATURAL HISTORY OF ATOPIC DERMATITIS. A 20-YEAR FOLLOW-UP STUDY. Arch Dermatol 1964; 89:209.
  65. Kemmett D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol 1991; 125:59.
  66. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62:385.
  67. Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ 2007; 335:152.
  68. Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol 2011; 165:943.
  69. Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev 2009; :CD007346.
  70. Chi CC, Mayon-White RT, Wojnarowska FT. Safety of topical corticosteroids in pregnancy: a population-based cohort study. J Invest Dermatol 2011; 131:884.
  71. Chi CC, Wang SH, Mayon-White R, Wojnarowska F. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. JAMA Dermatol 2013; 149:1274.
  72. www.reprotox.org (Accessed on August 31, 2010).